These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 9756091

  • 1. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy.
    Schrier RW, Fassett RG, Ohara M, Martin PY.
    Proc Assoc Am Physicians; 1998; 110(5):407-11. PubMed ID: 9756091
    [Abstract] [Full Text] [Related]

  • 2. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
    Schrier RW.
    Am J Med; 2006 Jul; 119(7 Suppl 1):S47-53. PubMed ID: 16843085
    [Abstract] [Full Text] [Related]

  • 3. Pathophysiology of renal fluid retention.
    Schrier RW, Fassett RG, Ohara M, Martin PY.
    Kidney Int Suppl; 1998 Sep; 67():S127-32. PubMed ID: 9736267
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
    Ma J, Peng A, Lin S.
    Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
    [Abstract] [Full Text] [Related]

  • 5. Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure.
    Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Suzuki K, Kodama M, Aizawa Y.
    Biochem Pharmacol; 2007 Nov 15; 74(10):1466-75. PubMed ID: 17720144
    [Abstract] [Full Text] [Related]

  • 6. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
    LeJemtel TH, Serrano C.
    Int J Cardiol; 2007 Aug 09; 120(1):1-9. PubMed ID: 17346825
    [Abstract] [Full Text] [Related]

  • 7. Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism.
    Chen YC, Cadnapaphornchai MA, Yang J, Summer SN, Falk S, Li C, Wang W, Schrier RW.
    Am J Physiol Renal Physiol; 2005 Oct 09; 289(4):F672-8. PubMed ID: 15914774
    [Abstract] [Full Text] [Related]

  • 8. Pathogenesis of water and sodium retention in cirrhosis.
    Martin PY, Schrier RW.
    Kidney Int Suppl; 1997 Jun 09; 59():S43-9. PubMed ID: 9185104
    [Abstract] [Full Text] [Related]

  • 9. Urinary excretion of aquaporin-2 and inappropriate secretion of vasopressin in hyponatremic patients after cerebral infarction.
    Takagi J, Otake K, Nakao N, Takashashi M, Hirooka Y.
    Horm Metab Res; 2003 Jan 09; 35(1):62-6. PubMed ID: 12669273
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aquaporin-2 water channels and vasopressin antagonists in edematous disorders.
    Schrier RW, Ohara M, Rogachev B, Xu L, Knotek M.
    Mol Genet Metab; 1998 Dec 09; 65(4):255-63. PubMed ID: 9889012
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genetic AVP deficiency abolishes cold-induced diuresis but does not attenuate cold-induced hypertension.
    Sun Z.
    Am J Physiol Renal Physiol; 2006 Jun 09; 290(6):F1472-7. PubMed ID: 16396942
    [Abstract] [Full Text] [Related]

  • 20. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
    Bishara B, Shiekh H, Karram T, Rubinstein I, Azzam ZS, Abu-Saleh N, Nitecki S, Winaver J, Hoffman A, Abassi ZA.
    J Pharmacol Exp Ther; 2008 Aug 09; 326(2):414-22. PubMed ID: 18467593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.